View Older Stories View More Recent Stories

May 30, 2018 09:00AM NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference
May 30, 2018 09:00AM NewLink Genetics to Participate in the Jefferies 2018 Global Healthcare Conference
May 16, 2018 05:01PM NewLink Genetics (NLNK) Says Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO
May 16, 2018 05:00PM NewLink Genetics Announces Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO 2018
May 16, 2018 05:00PM NewLink Genetics Announces Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO 2018
May 3, 2018 04:01PM NewLink Genetics Reports First Quarter 2018 Financial Results
May 3, 2018 04:01PM NewLink Genetics Reports First Quarter 2018 Financial Results
May 1, 2018 09:04AM NewLink Genetics (NLNK) Names Matthew L. Sherman to Board
May 1, 2018 09:00AM NewLink Genetics Appoints Matthew L. Sherman, M.D. to Board of Directors
May 1, 2018 09:00AM NewLink Genetics Appoints Matthew L. Sherman, M.D. to Board of Directors
Apr 30, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Apr 30, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Apr 25, 2018 03:55PM NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting
Apr 25, 2018 03:55PM NewLink Genetics Announces Presentation of Abstracts at ASCO 2018 Annual Meeting
Apr 20, 2018 09:00AM NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018
Apr 20, 2018 09:00AM NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018
Apr 17, 2018 09:00AM NewLink Genetics Describes the Differentiated Mechanism of Action of Indoximod in AACR Poster Presentation
Apr 16, 2018 05:56AM NewLink Genetics (NLNK) Reports Initial Phase 1 Data with Indoximod Plus Radiation & Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma
Apr 15, 2018 03:05PM NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary
Apr 15, 2018 03:05PM NewLink Genetics Announces Initial Phase 1 Data with Indoximod Plus Radiation and Chemotherapy for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG) Presented During AACR Plenary
Apr 6, 2018 03:03PM NewLink Genetics (NLNK) to Launch Review of Clinical Programs Following Announcement by Incyte and Merck
Apr 6, 2018 03:00PM NewLink Genetics Announces Review of Clinical Programs
Apr 6, 2018 03:00PM NewLink Genetics Announces Review of Clinical Programs
Apr 3, 2018 09:00AM NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
Apr 3, 2018 09:00AM NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
Mar 21, 2018 09:01AM NewLink Genetics (NLNK) Names Chad A. Johnson to Board
Mar 21, 2018 09:00AM NewLink Genetics Appoints Chad A. Johnson to Board of Directors
Mar 21, 2018 09:00AM NewLink Genetics Appoints Chad A. Johnson to Board of Directors
Mar 14, 2018 05:00PM NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting
Mar 14, 2018 05:00PM NewLink Genetics Announces Presentation of Abstracts at AACR Annual Meeting
Mar 12, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Mar 12, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Mar 1, 2018 04:01PM NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
Mar 1, 2018 04:01PM NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
Feb 16, 2018 09:00AM NewLink Genetics to Host Its Fourth Quarter and Year End 2017 Financial Results Conference Call on March 1, 2018
Feb 16, 2018 09:00AM NewLink Genetics to Host Its Fourth Quarter and Year End 2017 Financial Results Conference Call on March 1, 2018
Feb 6, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Feb 6, 2018 09:00AM NewLink Genetics to Participate in Upcoming Investor Conferences
Jan 8, 2018 08:06AM NewLink Genetics (NLNK) Announces 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 Inhibitors
Jan 8, 2018 08:00AM NewLink Genetics Outlines 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 Inhibitors
Jan 8, 2018 08:00AM NewLink Genetics Outlines 2018 Business Priorities to Support Phase 3 Pivotal Trial of Indoximod Plus PD-1 Inhibitors
Dec 21, 2017 09:00AM NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Dec 21, 2017 09:00AM NewLink Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Nov 27, 2017 09:24AM NewLink Genetics to Participate in Upcoming Investor Conference
Nov 20, 2017 04:25PM NewLink Genetics Announces the Presentation of Indoximod Data in Phase 1 Study for Children
Nov 14, 2017 09:01AM NewLink Genetics (NLNK) Appoints Eugene Kennedy as CMO
Nov 14, 2017 09:00AM NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer
Nov 13, 2017 10:30AM NewLink Genetics to Participate in November Investor Conferences
Nov 2, 2017 08:00AM NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program
Oct 30, 2017 09:02AM NewLink Genetics (NLNK) Granted FDA Orphan-Drug Designation for Indoximod
View More Recent Stories View Older Stories